{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:11Z","timestamp":1792785851134,"version":"4.5.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Vestre Viken Hospital Trust","id":[{"id":"https:\/\/ror.org\/03wgsrq67","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012446","name":"Akershus University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007793","name":"Kristian Gerhard Jebsen Foundation","doi-asserted-by":"publisher","award":["SKGJ-MED-024"],"award-info":[{"award-number":["SKGJ-MED-024"]}],"id":[{"id":"10.13039\/100007793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norwegian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013263","name":"Norwegian Health Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac myosin binding protein C (cMyC) is a cardiac-specific biomarker that is released after acute ischemic myocardial injury. Cardiac troponins are established cardiac biomarkers of myocardial injury and provide prognostic information in patients with cardiovascular disease (CVD) and in healthy persons from the general population. There is limited data documenting the prognostic value of cMyC in a general population setting. Accordingly, we assessed the prognostic value of cMyC for incident major adverse cardiovascular events (MACE) and mortality in a general population cohort and contrasted these associations with those of cardiac troponins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We measured cMyC, high-sensitivity cardiac troponin I (hs-cTnI), and high-sensitivity T (hs-cTnT) in serum samples from 3682 community dwellers born in 1950 at the baseline of the Akershus Cardiac Examination 1950 Study obtained from 2012 to 2015. We assessed the associations of all three biomarkers with a composite MACE outcome (nonfatal myocardial infarction, nonfatal ischemic stroke, nonfatal heart failure, myocardial revascularization, or cardiovascular mortality), as well as with all-cause, cardiovascular and non-cardiovascular mortality separately.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age was 63.9 years and 1885 were male. After a median follow-up of 8.3 years, we recorded 307 composite MACE outcomes and 191 deaths. cMyC was associated with risk of MACE, as was hs-cTnI and hs-cTnT (all P for log-rank test &amp;lt;0.001). cMyC remained independently associated with MACE (hazard ratio per 1 SD in log-transformed biomarker 1.25, 95% CI, 1.14\u20131.37) and cardiovascular death (hazard ratio 1.41, 95% CI 1.15\u20131.72) in adjusted analyses and after further adjustment for hs-cTnI or hs-cTnT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>cMyC provides strong prognostic information for incident CVD in the general population, independently of that provided by cardiac troponins.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvag082","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:56:01Z","timestamp":1783511761000},"page":"1056-1066","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Value of Cardiac Myosin Binding Protein C in the General Population: The Akershus Cardiac Examination 1950 Study"],"prefix":"10.1093","volume":"72","author":[{"given":"Torbj\u00f8rn","family":"Omland","sequence":"first","affiliation":[{"name":"Department of Cardiology, Division of Medicine, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]},{"name":"K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9434-7485","authenticated-orcid":false,"given":"Michael","family":"Paus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Division of Medicine, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]},{"name":"K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnljot","family":"Tveit","sequence":"additional","affiliation":[{"name":"Department of Medical Research, B\u00e6rum Hospital, Vestre Viken Hospital Trust , Gjettum ,","place":["Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trygve","family":"Berge","sequence":"additional","affiliation":[{"name":"Department of Medical Research, B\u00e6rum Hospital, Vestre Viken Hospital Trust , Gjettum ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulser","family":"Caliskan","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Brynildsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Division of Medicine, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7340-6736","authenticated-orcid":false,"given":"Kristin M","family":"Aakre","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Pharmacology; and Department of Heart Disease, Haukeland University Hospital , Bergen ,","place":["Norway"]},{"name":"Department of Clinical Science, University of Bergen , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"R\u00f8sj\u00f8","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]},{"name":"Akershus Clinical Research Center (ACR), Division of Research and Innovation, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus N","family":"Lyngbakken","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Centre for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]},{"name":"Akershus Clinical Research Center (ACR), Division of Research and Innovation, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2026100509520771900_hvag082-B1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10557-018-6845-3","article-title":"Cardiac myosin-binding protein C-from bench to improved diagnosis of acute myocardial infarction","volume":"33","author":"Kaier","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026100509520771900_hvag082-B2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ejhf.2094","article-title":"Cardiac myosin-binding protein C in the diagnosis and risk stratification of acute heart failure","volume":"23","author":"Kozhuharov","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026100509520771900_hvag082-B3","doi-asserted-by":"crossref","first-page":"31768","DOI":"10.1038\/s41598-025-16134-x","article-title":"Cardiac myosin-binding protein-C levels are associated with severity and prognosis in stable coronary artery disease","volume":"15","author":"Shen","year":"2025","journal-title":"Sci Rep"},{"key":"2026100509520771900_hvag082-B4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/clinchem\/hvaf013","article-title":"Determinants of cardiac myosin binding protein C in the general population","volume":"71","author":"Paus","year":"2025","journal-title":"Clin Chem"},{"key":"2026100509520771900_hvag082-B5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/heartjnl-2017-312257","article-title":"Cardiac myosin-binding protein C is a novel marker of myocardial injury and fibrosis in aortic stenosis","volume":"104","author":"Anand","year":"2018","journal-title":"Heart"},{"key":"2026100509520771900_hvag082-B6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"2026100509520771900_hvag082-B7","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"A sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"N Engl J Med"},{"key":"2026100509520771900_hvag082-B8","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(15)00391-8","article-title":"High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study","volume":"386","author":"Shah","year":"2015","journal-title":"Lancet"},{"key":"2026100509520771900_hvag082-B9","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.jacc.2017.08.064","article-title":"Stable high-sensitivity cardiac troponin T levels and outcomes in patients with chest pain","volume":"70","author":"Roos","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026100509520771900_hvag082-B10","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.2024.5596","article-title":"Prognostic value of cardiovascular biomarkers in the population","volume":"331","author":"Neumann","year":"2024","journal-title":"JAMA"},{"key":"2026100509520771900_hvag082-B11","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1373\/clinchem.2018.292086","article-title":"Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort","volume":"64","author":"Welsh","year":"2018","journal-title":"Clin Chem"},{"key":"2026100509520771900_hvag082-B12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/clinchem\/hvaa023","article-title":"Cardiac troponin I and T are associated with left ventricular function and structure: data from the akershus cardiac examination 1950 study","volume":"66","author":"Lyngbakken","year":"2020","journal-title":"Clin Chem"},{"key":"2026100509520771900_hvag082-B13","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1161\/CIRCULATIONAHA.118.038529","article-title":"Cardiac troponin T and troponin I in the general population","volume":"139","author":"Welsh","year":"2019","journal-title":"Circulation"},{"key":"2026100509520771900_hvag082-B14","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population","volume":"304","author":"de Lemos","year":"2010","journal-title":"JAMA"},{"key":"2026100509520771900_hvag082-B15","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/CIRCULATIONAHA.116.025505","article-title":"High-sensitive cardiac troponin T as an early biochemical signature for clinical and subclinical heart failure: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"135","author":"Seliger","year":"2017","journal-title":"Circulation"},{"key":"2026100509520771900_hvag082-B16","first-page":"308","article-title":"Heart and brain interactions\u2013the akershus cardiac examination (ACE) 1950 study design","volume":"49","author":"Berge","year":"2015","journal-title":"Scand Cardiovasc J"},{"key":"2026100509520771900_hvag082-B17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021704","article-title":"Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 study","volume":"8","author":"Berge","year":"2018","journal-title":"BMJ Open"},{"key":"2026100509520771900_hvag082-B18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trsl.2015.11.008","article-title":"The development and application of a high-sensitivity immunoassay for cardiac myosin-binding protein C","volume":"170","author":"Marjot","year":"2016","journal-title":"Transl Res"},{"key":"2026100509520771900_hvag082-B19","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2024.07.023","article-title":"Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis from COMBINE-AF","volume":"84","author":"Haller","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026100509520771900_hvag082-B20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013152","article-title":"Cardiac myosin-binding protein C to diagnose acute myocardial infarction in the pre-hospital setting","volume":"8","author":"Kaier","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026100509520771900_hvag082-B21","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.117.028084","article-title":"Direct comparison of cardiac myosin-binding protein C with cardiac troponins for the early diagnosis of acute myocardial infarction","volume":"136","author":"Kaier","year":"2017","journal-title":"Circulation"},{"key":"2026100509520771900_hvag082-B22","first-page":"325","article-title":"A 0\/1h-algorithm using cardiac myosin-binding protein C for early diagnosis of myocardial infarction","volume":"11","author":"Kaier","year":"2022","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026100509520771900_hvag082-B23","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.jacc.2025.09.008","article-title":"Incremental value of cardiac myosin-binding protein C for the early diagnosis of acute myocardial infarction","volume":"86","author":"Lopez-Ayala","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026100509520771900_hvag082-B24","doi-asserted-by":"crossref","first-page":"ehab724-1395","DOI":"10.1093\/eurheartj\/ehab724.1395","article-title":"Physiological circadian rhythm of cardiac myosin-binding protein C (cMyC) and cardiac troponin","volume":"42","author":"Alaour","year":"2021","journal-title":"Eur Heart J"},{"key":"2026100509520771900_hvag082-B25","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/sim.5727","article-title":"Testing for improvement in prediction model performance","volume":"32","author":"Pepe","year":"2013","journal-title":"Stat Med"},{"key":"2026100509520771900_hvag082-B26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12551-021-00840-7","article-title":"Cardiac sarcomere mechanics in health and disease","volume":"13","author":"Crocini","year":"2021","journal-title":"Biophys Rev"},{"key":"2026100509520771900_hvag082-B27","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/clinchem\/hvae107","article-title":"Implications of age for the diagnostic and prognostic value of cardiac troponin T and I","volume":"70","author":"Hasselbalch","year":"2024","journal-title":"Clin Chem"},{"key":"2026100509520771900_hvag082-B28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1373\/clinchem.2014.234369","article-title":"Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study","volume":"61","author":"Omland","year":"2015","journal-title":"Clin Chem"},{"key":"2026100509520771900_hvag082-B29","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/CIRCULATIONAHA.116.023726","article-title":"Impact of smoking on circulating cardiac troponin I concentrations and cardiovascular events in the general population: the HUNT study (Nord-Trondelag Health Study)","volume":"134","author":"Lyngbakken","year":"2016","journal-title":"Circulation"},{"key":"2026100509520771900_hvag082-B30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12933-023-02003-2","article-title":"Association between high sensitivity cardiac troponin and mortality risk in the non-diabetic population: findings from the National Health and Nutrition Examination Survey","volume":"22","author":"Liu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2026100509520771900_hvag082-B31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/clinchem\/hvag011","article-title":"Establishing reference values in healthy participants for the cardiac troponin T high-sensitivity gen 6 assay: REF-TSIX global reference study","volume":"72","author":"Daniels","year":"2026","journal-title":"Clin Chem"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/10\/1056\/69192268\/hvag082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/10\/1056\/69192268\/hvag082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:52:19Z","timestamp":1791208339000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/72\/10\/1056\/8736899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,7,17]]},"published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvag082","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,7,17]]}}}